ACO ASSO

• Combined hepatocellular-cholangiocarcinoma: An analysis of clinicopathological characteristics after surgery.
• Single-Port Laparoscopic Hepatectomy for Liver Tumor: Operative Steps (With Video).
• Clinical outcome of open surgery versus laparoscopic surgery for cirrhotic hepatocellular carcinoma patients: a meta-analysis.
• Variation in the Use of Resection for Colorectal Cancer Liver Metastases.
• Screening high risk populations for cancer: Hepatobiliary.
• Extrahepatic Cholangiocarcinoma: What the Surgeon Needs to Know RadioGraphics Fundamentals | Online Presentation.
• Parenchymal sparing surgery brings treatment of colorectal liver metastases into the precision medicine era.

• Emerging pathways for precision medicine in management of cholangiocarcinoma.
• Elderly Hepatocellular Carcinoma Patients: Open or Laparoscopic Approach?
• Postoperative liver regeneration does not elicit recurrence of colorectal cancer liver metastases after major hepatectomy.
• Preoperative leukocytosis and the resection severity index are independent risk factors for survival in patients with intrahepatic cholangiocarcinoma.
• ASO Author Reflections: Poorest Survival Outcomes in Patients with Right Colon Cancer with KRAS Mutation After Simultaneous Curative-Intent Surgery for Colorectal Cancer Liver Metastases.
• Simultaneous Sigmoid Colectomy, Bilobar Liver Resection and Lung Metastasectomy via a Transdiaphragmatic Approach for Stage IV Colonic Adenocarcinoma.
• Invasion category-oriented lymph node metastases of cholangiocarcinoma and the prognostic impact.Prognosis of Synchronous Colorectal Liver Metastases After Simultaneous Curative-Intent Surgery According to Primary Tumor Location and KRAS Mutational Status.
• Guidelines Adaptation to the COVID-19 Outbreak for the Management of Hepatocellular Carcinoma.
• Intention-to-treat curative liver resection in patients with "very early" intrahepatic cholangiocarcinoma.
• Pure Laparoscopic Right Hepatectomy for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus (with Video).
• Impact of hepatitis C treatment on long-term outcomes for patients with hepatocellular carcinoma: a United States Safety Net Collaborative Study.
• Laparoscopic major hepatectomy for hepatocellular carcinoma in elderly patients: a multicentric propensity score‑based analysis.
• Is Portal Vein Embolization Followed by Hepatectomy for Hepatocellular Carcinoma Justified in Patients with Impaired Liver Function?
• Management of hepatocellular carcinoma in the time of COVID-19.
• Author’s Reply: Risk Factors and Outcome of Portal Vein Thrombosis After Laparoscopic and Open Hepatectomy for Primary Liver Cancer: A Single-Center Experience.
• [Results of simultaneous resection and classical strategy for synchronous liver metastases of colorectal cancer].

„ACO – Heppanc-1, synchrone Resektion beim minimal hepatal metastasierten Pankreaskarzinom nach neoadjuvanter Chemotherapie“ 

Einladungsbrief ACO-Heppanc-1

• Primary Tumor Location Is a Prognostic Factor for Intrahepatic Progression-Free Survival in Patients with Colorectal Liver Metastases Undergoing Portal Vein Embolization as Preparation for Major Hepatic Surgery.
• ASO Author Reflections: Assessing the Value of Primary Tumor Resection in Midgut Neuroendocrine Tumors with Liver-Only Metastases.
• Resection of recurrent hepatocellular carcinoma with thrombi in the inferior vena cava, right atrium, and phrenic vein: a report of three cases.
• The Microbiome and Hepatocellular Carcinoma.
• A novel model for predicting posthepatectomy liver failure based on liver function and degree of liver resection in patients with hepatocellular carcinoma.
• Laparoscopic liver resection versus open liver resection for intrahepatic cholangiocarcinoma: 3-year outcomes of a cohort study with propensity score matching.
• Perihilar cholangiocarcinoma: A different concept for radical resection.
• Future liver remnant function as a predictor of postoperative morbidity following liver resection for hepatocellular carcinoma – A risk factor analysis.
• Local and Regional Therapies for Hepatocellular Carcinoma.
• Laparoscopic repeat hepatectomy is a more favorable treatment than open repeat hepatectomy for contralateral recurrent hepatocellular carcinoma cases.

• The impact of metabolic syndrome (MetS) on surgical outcome for patients with mostly HBV-related hepatocellular carcinoma (HCC) underwent hepatectomy.
• Pre-sarcopenia is the prognostic factor of overall survival in early-stage hepatoma patients undergoing radiofrequency ablation.
• Treatment of solitary hepatocellular carcinoma up to 2 cm: A PRISMA-compliant systematic review and meta-analysis.
• The Tumor Microenvironment in Cholangiocarcinoma Progression.
• Is Postoperative Adjuvant Transcatheter Arterial Infusion Therapy Effective for Patients with Hepatocellular Carcinoma who Underwent Hepatectomy? A Prospective Randomized Controlled Trial.
• Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?
• Nonsurgical management of advanced hepatocellular carcinoma: a clinical practice guideline.
• Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer.
• Combined hepatectomy and microwave ablation for multifocal hepatocellular carcinoma: Long-term outcomes and prognostic factors.
• Microwave ablation versus other interventions for hepatocellular carcinoma: A systematic review and meta-analysis.
• Pure Laparoscopic Anatomical Resection of Segment 4b for Hepatocellular Carcinoma Using the Transfissural Glissonean Approach.
• Technical Insights on Laparoscopic Left and Right Hepatectomy for Perihilar Cholangiocarcinoma.

• Laparoscopic Versus Open Thermal Ablation of Colorectal Liver Metastases: A Propensity Score-Based Analysis of Local Control of the Ablated Tumors.
• Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) – a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trial.
• The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
• Safety margin assessment after microwave ablation of liver tumors: inter- and intrareader variability.
• Clinical Outcomes of Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma.
• Prognostic significance of and risk prediction model for lymph node metastasis in resectable intrahepatic cholangiocarcinoma: do all require lymph node dissection?
• Effect of surgical margin width after R0 resection for intrahepatic cholangiocarcinoma: A nationwide survey of the Liver Cancer Study Group of Japan.
• Prospective double-blinded randomized controlled trial of Microwave versus RadioFrequency Ablation for hepatocellular carcinoma (McRFA trial).
• Robotic right hepatectomy for a central liver tumor- A video of the surgical technique.

• Prognostic role of preoperative albumin-bilirubin grade on patients with hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis.
• Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
• Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer.
• Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis.
• Laparoscopic versus open limited liver resection for hepatocellular carcinoma with liver cirrhosis: a propensity score matching study with the Hiroshima Surgical study group of Clinical Oncology (HiSCO).
• Long term recurrence free survival in a stage IV gallbladder cancer treated with chemotherapy plus trastuzumab and salvage liver resection.
• Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: Hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma.
• Repeat liver resection versus salvage liver transplant for recurrent hepatocellular carcinoma: A propensity score-adjusted and -matched comparison analysis.
• Intraoperative radiofrequency ablation and distilled water peritoneal lavage for spontaneously ruptured hepatocellular carcinoma.
• Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1).
• Cholecystitis and risk of pancreatic, liver, and biliary tract cancer in patients undergoing cholecystectomy.

• Ischemic Cholangiopathy Following Transcatheter Arterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy: an Underestimated and Devastating Complication.
• Long-Term and Oncologic Outcomes of Robotic Versus Laparoscopic Liver Resection for Metastatic Colorectal Cancer: A Multicenter, Propensity Score Matching Analysis.
• Hepatic resection after neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer: need for cautious planning.
• Histological tumor response assessment in colorectal liver metastases after neoadjuvant chemotherapy: impact of the variation in tumor regression grading and peritumoral lymphocytic infiltration.
• Liver microwave ablation: a systematic review of various FDA-approved systems.
• Liver Resection Is Justified in Patients with BCLC Intermediate Stage Hepatocellular Carcinoma without Microvascular Invasion.
• Locoregional Therapy, Immunotherapy and the Combination in Hepatocellular Carcinoma: Future Directions.
• Robotic hepatic surgery in malignancy: review of the current literature.
• Hamartomas and malformations of the liver.

• Laparoscopic liver resection for liver tumours in proximity to major vasculature: A single-center comparative study.
• Resection of intrahepatic cholangiocarcinoma in elderly patients – is it reasonable?
• Total laparoscopic versus open radical resection for hilar cholangiocarcinoma.
• Shrinkage of hepatocellular carcinoma after radiofrequency ablation following transcatheter arterial chemoembolization: Analysis of contributing factors.

• Purely laparoscopic extended right hemihepatectomy for hepatocellular carcinoma with bile duct tumor thrombus.
• Liver Resection Versus Embolization for Recurrent Hepatocellular Carcinoma.
• Laparoscopic repeat hepatectomy for treating recurrent liver cancer.
• Simultaneous resection of colorectal cancer with synchronous liver metastases; a practice survey.
• Stereotactic radiofrequency ablation of primary liver tumors in the caudate lobe.
• The outcome of the HCC patients underwent ALPPS: Retrospective study.
• Combined hepatocellular-cholangiocarcinoma: An analysis of clinicopathological characteristics after surgery.
• Local Therapy in Advanced Cholangiocarcinoma: A Review of Current Endoscopic, Medical, and Oncologic Treatment Options.
• ALPPS Versus Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastases.

• Combined hepatocellular-cholangiocarcinoma: An analysis of clinicopathological characteristics after surgery.
• Single-Port Laparoscopic Hepatectomy for Liver Tumor: Operative Steps (With Video).
• Clinical outcome of open surgery versus laparoscopic surgery for cirrhotic hepatocellular carcinoma patients: a meta-analysis.
• Variation in the Use of Resection for Colorectal Cancer Liver Metastases.
• Screening high risk populations for cancer: Hepatobiliary.
• Extrahepatic Cholangiocarcinoma: What the Surgeon Needs to Know RadioGraphics Fundamentals | Online Presentation.
• Parenchymal sparing surgery brings treatment of colorectal liver metastases into the precision medicine era.

Hotel scalaria, SR VI
12:00 – 12:45 Uhr

• Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?
• Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.
• Prognostic factors influencing survival in small bowel neuroendocrine tumor with liver metastases.
• Safety and efficacy of locoregional therapy for metastatic pancreatic ductal adenocarcinoma to the liver: a single-center experience.
• Liver transplantation for unresectable malignancies: Beyond hepatocellular carcinoma.
• Left- versus right-sided hepatectomy with hilar en-bloc resection in perihilar cholangiocarcinoma.
• [Influence of tumor-free resection margins on overall and disease-free survival after resection of colorectal liver metastases].
• [Partial liver resection vs. transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria and portal hypertension].
• [Liver resection for hepatocellular carcinoma with portal vein infiltration].
• [Importance of the lymph node status in patients with hilar cholangiocarcinoma].
• [Perihilar cholangiocarcinoma Bismuth type IV: Resection frequently possible].
• [Importance of repeated liver resection in recurrent intrahepatic cholangiocarcinoma].
• [Treatment effect of liver resection vs. RFA or TACE in hepatocellular carcinoma].
• [Importance of portal vein embolization depending on the underlying hepatic malignancy].
• [Unresectable intrahepatic cholangiocarcinoma: 50 % resectability after neoadjuvant therapy].
• Gastrectomy Alone or in Combination With Hepatic Resection in the Management of Liver Metastases From Gastric Cancer: A Systematic Review Using an Updated and Cumulative Meta-Analysis.
• Hepatic Resection Following Selective Internal Radiation Therapy for Colorectal Cancer Metastases in the FOXFIRE Clinical Trial: Clinical Outcomes and Distribution of Microspheres.
• Spontaneous rupture of hepatocellular carcinoma: Optimal timing of partial hepatectomy.
• The Management of Colorectal Cancer Liver Metastases: The Interventional Radiology Viewpoint.
• Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.
• Surgical Resection of Hepatic Epithelioid Hemangioendothelioma.

• Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study.
• Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis.
• Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
• Stenting for Benign and Malignant Biliary Strictures.
• Laparoscopic right posterior sectionectomy: single-center experience and technical aspects.
• Tumor Size Drives the Prognosis After Hepatic Resection of Solitary Hepatocellular Carcinoma Without Vascular Invasion.
• Combined Transarterial Embolization/Chemoembolization-Based Locoregional Treatment with Sorafenib Prolongs the Survival in Patients with Advanced Hepatocellular Carcinoma and Preserved Liver Function: A Propensity Score Matching Study.
• Microwave ablation compared with hepatic resection for the treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis.

• Does lymphovascular invasion really associate with decreased overall survival for patients with resected cholangiocarcinoma?
• Long-term perioperative outcomes of pure laparoscopic liver resection versus open liver resection for hepatocellular carcinoma: a retrospective study.
• Preoperative course of patients undergoing endoscopic naso-biliary drainage during the management of resectable perihilar cholangiocarcinoma.
• Prognostic significance of primary tumor sidedness in patients undergoing liver resection for metastatic colorectal cancer.
• Preoperative Chemotherapy and Resection Margin Status in Colorectal Liver Metastasis Patients: A Propensity Score-Matched Analysis.
• Impact of contrast ultrasound diagnosis for patients with liver cancer.
• Extended Lymphadenectomy Versus Regional Lymphadenectomy in Resectable Hilar Cholangiocarcinoma.
• Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.
• Extended resection of intrahepatic cholangiocarcinoma: A retrospective single-center cohort study.
• Role of Repeat Resection in Patients With Metastatic Colorectal Cancer: A Multicenter Retrospective Study.
• Middle Hepatic Vein Roadmap for a Safe Laparoscopic Right Hepatectomy.
• Robotic Repeat Right Hepatectomy for Recurrent Colorectal Liver Metastasis.
• Long-Term Implications of Unplanned Conversion During Laparoscopic Liver Resection for Hepatocellular Carcinoma.
• A Systematic Review and Meta-Analysis Comparing the Short- and Long-Term Outcomes for Laparoscopic and Open Liver Resections for Hepatocellular Carcinoma: Updated Results from the European Guidelines Meeting on Laparoscopic Liver Surgery, Southampton, UK, 2017.
• Totally Laparoscopic ALPPS: Bilobar Procedure with Preservation of the S3 Portobiliary Triad.
• Clinical Benefit of Preoperative Exercise and Nutritional Therapy for Patients Undergoing Hepato-Pancreato-Biliary Surgeries for Malignancy.
• Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases.
• Ventral Approach to the Middle Hepatic Vein During Laparoscopic Hemihepatectomy.
• Elective Regional Therapy Treatment for Hepatic Adenoma.

• Evaluation of the utility of prognostic models for patients with resected hilar cholangiocarcinoma.
• ASO Author Reflections: Understanding Recurrence Patterns and Time Courses of Intrahepatic Cholangiocarcinoma After Surgery Helps in Postoperative Surveillance and Treatment.
• Hepatocellular carcinoma: killing one bird with two stones.
• Validation of combination treatment with surgical spacer placement and subsequent particle radiotherapy for unresectable hepatocellular carcinoma.
• Single Hepatocellular Carcinoma approached by curative-intent treatment: A propensity score analysis comparing radiofrequency ablation and liver resection.
• The role of sarcopenia in patients with intrahepatic cholangiocarcinoma: Prognostic marker or hyped parameter?
• Macrophages in Colorectal Cancer Liver Metastases.
• Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival.
• Conventional Chemoembolization Plus Radiofrequency Ablation versus Surgical Resection for Single, Medium-Sized Hepatocellular Carcinoma: Propensity-Score Matching Analysis.
• Surgical resection of neuroendocrine tumor liver metastases as part of multimodal treatment strategies: A propensity score matching analysis.

• Antimicrobial prophylaxis for 1 day versus 3 days in liver cancer surgery: a randomized controlled non-inferiority trial.
• Risk factors and prognosis of patients with recurrent hepatocellular carcinoma who undergo liver re-resections.
• Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: different strategies for curative treatment?
• Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.
• Hepatocellular carcinoma in the noncirrhotic liver: a literature review.
• Intrahepatic Oxaliplatin and Systemic 5-FU +/- Cetuximab in Chemo-Naïve Patients with Liver Metastases from Colorectal Cancer.
• Hepatectomy for hepatocellular carcinoma after perioperative management of portal hypertension.
• A systematic review and meta-analysis comparing the short- and long-term outcomes for laparoscopic and open liver resections for liver metastases from colorectal cancer.
• Efficacy and safety of radiofrequency ablation versus minimally invasive liver surgery for small hepatocellular carcinoma: a systematic review and meta-analysis.
• Improved outcomes with surgery compared to radiofrequency ablation in the treatment of resectable hepatocellular carcinoma.
• Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection.
• Does the site of primary colorectal cancer influence the outcome after resection of isolated liver metastases?
• Treatment options for PNET liver metastases: a systematic review.

• Defining enhanced recovery after resection of peri-hilar cholangiocarcinoma.
• Hepatocellular Carcinoma.
• Minimally invasive resection of posterosuperior liver tumors in the supine position using intra-abdominal trocars.
• Relevance of Preoperative Hyperbilirubinemia in Patients Undergoing Hepatobiliary Resection for Hilar Cholangiocarcinoma.

• Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study.
• Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis.
• Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis.
• Systematic review and meta-analysis of laparoscopic versus open repeat hepatectomy for recurrent liver cancer.
• Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma.
• Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery.
• Nonresectional regional therapies for metastatic colorectal cancer to the liver.
• Hepatocellular carcinoma: resection with adjuvant hepatic artery infusion therapy vs resection alone. A systematic review and meta-analysis.
• Robotic hepatectomy for benign and malignant liver tumors.
• Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma.
• Liver Resection for Solitary Transplantable Hepatocellular Carcinoma: The Role of AFP-Score.

• Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis.
• Malnutrition associated with an increased risk of postoperative complications following hepatectomy in patients with hepatocellular carcinoma.
• Influence of tumor-free resection margins on overall and disease-free survival after resection of colorectal liver metastases.
• Partial liver resection vs. transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria and portal hypertension.

Chirurg 2019

• Liver resection for hepatocellular carcinoma with portal vein infiltration.
• Importance of the lymph node status in patients with hilar cholangiocarcinoma.
• Perihilar cholangiocarcinoma Bismuth type IV: Resection frequently possible.
• Importance of repeated liver resection in recurrent intrahepatic cholangiocarcinoma.
• Treatment effect of liver resection vs. RFA or TACE in hepatocellular carcinoma.
• Importance of portal vein embolization depending on the underlying hepatic malignancy.
• Unresectable intrahepatic cholangiocarcinoma: 50 % resectability after neoadjuvant therapy.

• Surgical therapy of primary hepatic angiosarcoma.
• Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases.